{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:43:59Z","timestamp":1782225839335,"version":"3.54.5"},"reference-count":56,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Radioimmunotherapy (RIT) is used to treat patients with hematologic malignancies known to infiltrate the bone marrow (BM) microenvironment. RIT uses target-specific monoclonal antibodies stably conjugated to radionuclides to deliver cytotoxic radiation to cells of interest. Although RIT is effective at delivering radiation to cancer cells, normal tissue is also exposed to radiation during RIT, the consequences of which are largely unknown. Here, we studied the cellular and molecular effects of CD45-targeted astatine-211 (211At) RIT, immunoglobulin G (IgG) nontargeted 211At RIT, and Cesium-137 total-body irradiation (TBI) on hematopoietic cells and their BM niche in wild-type immunocompetent mice. Relative to nontargeted RIT or TBI, CD45-targeted RIT significantly delayed hematopoietic regeneration overall in the peripheral blood and BM and reduced hematopoietic stem\/progenitor cell recovery and colony-forming ability. Although BM endothelial cells (ECs) do not express the CD45 antigen, CD45-targeted RIT significantly depleted BM ECs compared to nontargeted RIT or TBI. RNA sequence analysis revealed significantly different transcriptomic profiles of BM ECs from CD45-RIT\u2013treated mice compared to nontargeted RIT or TBI. ECs from CD45-RIT\u2013treated mice, but not TBI\u2013 or IgG-RIT\u2013treated mice, were transcriptionally enriched for growth factor signaling pathways compared to untreated mice. BM soluble growth factor expression remained upregulated in CD45-RIT\u2013treated mice 28 days after treatment compared to nontreated mice. Collectively, our study indicates that CD45-targeted RIT severely affects hematopoietic and EC niche recovery compared to nontargeted approaches. Future studies are required to determine the long-term consequences of such RIT-driven effects on BM niche physiology and how BM niche reprogramming by RIT affects cancer cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017065","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:57:02Z","timestamp":1770839822000},"page":"2452-2469","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-2262","authenticated-orcid":false,"given":"Matthew W.","family":"Hagen","sequence":"first","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-0274","authenticated-orcid":false,"given":"Nicollette J.","family":"Setiawan","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-8901","authenticated-orcid":false,"given":"Shannon","family":"Dexter","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1923-1813","authenticated-orcid":false,"given":"Kelsey A.","family":"Woodruff","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2426-9325","authenticated-orcid":false,"given":"Francesca K.","family":"Gaerlan","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5614-0115","authenticated-orcid":false,"given":"Taylor M.","family":"Billings","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-4680","authenticated-orcid":false,"given":"Johnnie J.","family":"Orozco","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"3Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-1347","authenticated-orcid":false,"given":"Christina M.","family":"Termini","sequence":"additional","affiliation":[{"name":"1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"4Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"10","key":"2026041408031315900_bib1","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1016\/S2352-3026(24)00247-3","article-title":"Radiotherapy for haematological malignancies","volume":"11","author":"Dee","year":"2024","journal-title":"Lancet Haematol"},{"issue":"3","key":"2026041408031315900_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2019.02.001","article-title":"The optimal use of imaging in radiation therapy for lymphoma: guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"104","author":"Mikhaeel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2026041408031315900_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2026041408031315900_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Ozdemir","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"2026041408031315900_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2307\/3579579","article-title":"Alpha-emitters for medical therapy: workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996","volume":"148","author":"Feinendegen","year":"1997","journal-title":"Radiat Res"},{"issue":"11","key":"2026041408031315900_bib6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/0360-3016(87)90176-3","article-title":"A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy","volume":"13","author":"Humm","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2026041408031315900_bib7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2967\/jnumed.124.267540","article-title":"211At-labeled anti-CD45 antibody as a nonmyeloablative conditioning for canine DLA-haploidentical stem cell transplantation","volume":"65","author":"Frost","year":"2024","journal-title":"J Nucl Med"},{"issue":"3","key":"2026041408031315900_bib8","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S2666-6367(21)00083-X","article-title":"A phase I trial of first-in-human alpha-emitter astatine-211-labeled anti-CD45 antibody (211At-BC8-B10) in combination with fludarabine and TBI as conditioning for allogeneic hematopoietic cell transplantation (HCT) for patients with refractory\/relapsed leukemia or high-risk myelodysplastic syndrome (MDS): preliminary results of dose escalation [abstract]","volume":"27","author":"Sandmaier","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2026041408031315900_bib10","doi-asserted-by":"crossref","first-page":"1076210","DOI":"10.3389\/fmed.2022.1076210","article-title":"Astatine-211 based radionuclide therapy: current clinical trial landscape","volume":"9","author":"Albertsson","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2026041408031315900_bib11","unstructured":"211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia. Accessed 1 July 2025. https:\/\/clinicaltrials.gov\/study\/NCT03128034."},{"key":"2026041408031315900_bib12","unstructured":"A Phase I Trial Evaluating Escalating Doses of 211At-Labeled Anti-CD38 Monoclonal Antibody Followed by HLA-Matched or Haploidentical Donor Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma. Accessed 1 July 2025. https:\/\/clinicaltrials.gov\/study\/NCT03128034."},{"issue":"4","key":"2026041408031315900_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/bc0100096","article-title":"Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability","volume":"12","author":"Wilbur","year":"2001","journal-title":"Bioconjug Chem"},{"issue":"18","key":"2026041408031315900_bib14","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2012-11-467035","article-title":"Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model","volume":"121","author":"Orozco","year":"2013","journal-title":"Blood"},{"key":"2026041408031315900_bib15","first-page":"53936","article-title":"Murine hind limb long bone dissection and bone marrow isolation","volume":"110","author":"Amend","year":"2016","journal-title":"J Vis Exp"},{"issue":"3","key":"2026041408031315900_bib16","doi-asserted-by":"crossref","first-page":"370.e5-381.e5","DOI":"10.1016\/j.stem.2018.07.003","article-title":"Distinct bone marrow sources of pleiotrophin control hematopoietic stem cell maintenance and regeneration","volume":"23","author":"Himburg","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2026041408031315900_bib17","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-08-4363","article-title":"Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211","volume":"69","author":"Nakamae","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"2026041408031315900_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.191.2.253","article-title":"The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential","volume":"191","author":"Domen","year":"2000","journal-title":"J Exp Med"},{"issue":"7","key":"2026041408031315900_bib19","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/blood.V91.7.2272","article-title":"Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation","volume":"91","author":"Domen","year":"1998","journal-title":"Blood"},{"issue":"5272","key":"2026041408031315900_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.273.5272.242","article-title":"Long-term lymphohematopoietic reconstitution by a single CD34-low\/negative hematopoietic stem cell","volume":"273","author":"Osawa","year":"1996","journal-title":"Science"},{"issue":"suppl 1","key":"2026041408031315900_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/stem.5530150803","article-title":"In vitro expansion of hematopoietic stem cells","volume":"15","author":"Ogawa","year":"1997","journal-title":"Stem Cells"},{"issue":"2","key":"2026041408031315900_bib22","first-page":"299","article-title":"Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential","volume":"24","author":"Traycoff","year":"1996","journal-title":"Exp Hematol"},{"issue":"9","key":"2026041408031315900_bib23","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.V85.9.2598.bloodjournal8592598","article-title":"Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors","volume":"85","author":"van der Loo","year":"1995","journal-title":"Blood"},{"issue":"9","key":"2026041408031315900_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41576-020-0241-0","article-title":"Haematopoietic stem cell self-renewal in vivo and ex vivo","volume":"21","author":"Wilkinson","year":"2020","journal-title":"Nat Rev Genet"},{"issue":"16","key":"2026041408031315900_bib25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.2020005699","article-title":"VEGF-C protects the integrity of the bone marrow perivascular niche in mice","volume":"136","author":"Fang","year":"2020","journal-title":"Blood"},{"issue":"12","key":"2026041408031315900_bib26","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1172\/JCI92309","article-title":"Endothelial jagged-2 sustains hematopoietic stem and progenitor reconstitution after myelosuppression","volume":"127","author":"Guo","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2026041408031315900_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2009.01.006","article-title":"Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells","volume":"4","author":"Hooper","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2026041408031315900_bib28","doi-asserted-by":"crossref","first-page":"768.e6-783.e6","DOI":"10.1016\/j.stem.2019.10.006","article-title":"Apelin+ endothelial niche cells control hematopoiesis and mediate vascular regeneration after myeloablative injury","volume":"25","author":"Chen","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2026041408031315900_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.stem.2010.02.001","article-title":"Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells","volume":"6","author":"Butler","year":"2010","journal-title":"Cell stem cell"},{"issue":"1","key":"2026041408031315900_bib30","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1038\/s41467-021-27263-y","article-title":"Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution","volume":"12","author":"Termini","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"2026041408031315900_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1667\/RR14444.1","article-title":"A molecular profile of the endothelial cell response to ionizing radiation","volume":"186","author":"Himburg","year":"2016","journal-title":"Radiat Res"},{"issue":"5","key":"2026041408031315900_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s44161-022-00064-2","article-title":"Syndecan-2 selectively regulates VEGF-induced vascular permeability","volume":"1","author":"Corti","year":"2022","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"2026041408031315900_bib33","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s41467-019-09605-z","article-title":"N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization","volume":"10","author":"Corti","year":"2019","journal-title":"Nat Commun"},{"issue":"17","key":"2026041408031315900_bib34","doi-asserted-by":"crossref","first-page":"e147472","DOI":"10.1172\/jci.insight.147472","article-title":"COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction","volume":"6","author":"Queisser","year":"2021","journal-title":"JCI Insight"},{"issue":"12","key":"2026041408031315900_bib35","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1084\/jem.20090778","article-title":"Niche recycling through division-independent egress of hematopoietic stem cells","volume":"206","author":"Bhattacharya","year":"2009","journal-title":"J Exp Med"},{"issue":"5854","key":"2026041408031315900_bib36","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"issue":"suppl 1","key":"2026041408031315900_bib37","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2024-205992","article-title":"CD45-directed radioimmunotherapy with the alpha-emitter astatine-211 as conditioning for autologous hematopoietic stem\/progenitor cell gene therapy: results from a nonhuman primate model","volume":"144","author":"Radtke","year":"2024","journal-title":"Blood"},{"issue":"10","key":"2026041408031315900_bib38","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"issue":"10","key":"2026041408031315900_bib39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1701754","article-title":"Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis","volume":"23","author":"Matthes-Martin","year":"1999","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2026041408031315900_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood-2001-12-0322","article-title":"Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts","volume":"100","author":"Sandmaier","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2026041408031315900_bib41","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2011-09-380436","article-title":"Durable donor engraftment after radioimmunotherapy using alpha-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2026041408031315900_bib42","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2967\/jnumed.115.162388","article-title":"\u03b1-imaging confirmed efficient targeting of CD45-positive cells after 211At-radioimmunotherapy for hematopoietic cell transplantation","volume":"56","author":"Frost","year":"2015","journal-title":"J Nucl Med"},{"issue":"5","key":"2026041408031315900_bib43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14712598.2022.2060735","article-title":"Where do we stand with radioimmunotherapy for acute myeloid leukemia?","volume":"22","author":"Walter","year":"2022","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"2026041408031315900_bib44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1211\/jpp.60.8.0006","article-title":"New insights into the mechanisms of action of radioimmunotherapy in lymphoma","volume":"60","author":"Ivanov","year":"2008","journal-title":"J Pharm Pharmacol"},{"issue":"732","key":"2026041408031315900_bib45","doi-asserted-by":"crossref","first-page":"eadg6229","DOI":"10.1126\/scitranslmed.adg6229","article-title":"TGF-\u03b2R2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue","volume":"16","author":"Zhao","year":"2024","journal-title":"Sci Transl Med"},{"issue":"3","key":"2026041408031315900_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.20121610","article-title":"TGF\u03b2 restores hematopoietic homeostasis after myelosuppressive chemotherapy","volume":"210","author":"Brenet","year":"2013","journal-title":"J Exp Med"},{"issue":"11","key":"2026041408031315900_bib47","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3324\/haematol.2018.208660","article-title":"A Tie2-Notch1 signaling axis regulates regeneration of the endothelial bone marrow niche","volume":"104","author":"Shao","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"2026041408031315900_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ncb3570","article-title":"Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2026041408031315900_bib49","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbmt.2014.05.014","article-title":"Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome","volume":"20","author":"Mawad","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2026041408031315900_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/JCO.23.02018","article-title":"Randomized phase III SIERRA trial of 131I-apamistamab before allogeneic hematopoietic cell transplantation versus conventional care for relapsed\/refractory AML","volume":"43","author":"Gyurkocza","year":"2025","journal-title":"J Clin Oncol"},{"issue":"27","key":"2026041408031315900_bib51","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1182\/blood-2009-03-213298","article-title":"Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome","volume":"114","author":"Pagel","year":"2009","journal-title":"Blood"},{"issue":"suppl 1","key":"2026041408031315900_bib52","first-page":"637","article-title":"Anti-CD45 monoclonal antibody (MAb) dose optimization for astatine-211 (211At)-radioimmunotherapy (RIT) of relapsed non-Hodgkin lymphoma (NHL) in a canine model","volume":"55","author":"Frost","year":"2014","journal-title":"J Nucl Med"},{"issue":"6","key":"2026041408031315900_bib53","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41375-022-01580-7","article-title":"Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies","volume":"36","author":"Laszlo","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"2026041408031315900_bib54","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.2019001250","article-title":"The alpha-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model","volume":"134","author":"O'Steen","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2026041408031315900_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/bloodadvances.2024013214","article-title":"Measurable residual disease as predictor of post-day +100 relapses after allografting in adult AML","volume":"9","author":"Ali","year":"2025","journal-title":"Blood Adv"},{"issue":"4","key":"2026041408031315900_bib56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/cells14040290","article-title":"Significance of measurable residual disease in patients undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"14","author":"Gang","year":"2025","journal-title":"Cells"},{"issue":"2","key":"2026041408031315900_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41375-024-02497-z","article-title":"Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia","volume":"39","author":"Orvain","year":"2025","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2452\/2512281\/blooda_adv-2025-017065-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2452\/2512281\/blooda_adv-2025-017065-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:03:28Z","timestamp":1776168208000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2452\/566564\/The-bone-marrow-niche-and-hematopoietic-system-are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017065","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,4,2]]}}}